KAWASAKI DISEASE DETERMINATION KIT AND KAWASAKI DISEASE DETERMINATION METHOD

MARKERS FOR THE DIAGNOSIS OF BIOCHEMICAL RECURRENCE IN PROSTATE CANCER

KIT FOR DIAGNOSING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE

HDL-ASSOCIATED PROTEIN BIOMARKER PANEL DETECTION

COMPOSITION FOR USE TO SUPPRESS INHIBITION OF APOE MEASUREMENT BY LIPID AND USE THEREOF

METHOD OF PROGNOSIS AND FOLLOW UP OF PRIMARY LIVER CANCER

BLADDER CANCER BIOMARKERS AND METHODS OF USE

METHODS FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

APOB:CFAS CONTENT TO AID IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES

BIOMARKERS FOR OVARIAN CANCER

METHODS FOR CHARACTERIZING AN ADNEXAL MASS

COMBINATION OF BIOMARKERS, AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION OR RISK THEREOF BY USING SAID COMBINATION

APOLIPOPROTEIN A-II BIOMARKERS FOR DETECTING AND MONITORING CANCERS

Device and Methods

3D BIOASSAYS TO MEASURE ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY

METHOD AND KIT FOR DIAGNOSING ALZHEIMER'S DISEASE BASED ON THE DETECTION OF APOLIPOPROTEIN E

TREATMENT OF LUPUS NEPHRITIS WITH ANTI-TYPE I INF RECEPTOR ANTIBODY ANIFROLUMAB

INFECTION DIAGNOSIS AND CHARACTERIZATION USING DIFFUSION AND RELAXATION EDITED PROTON NMR SPECTROSCOPY

SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT

HDL-ASSOCIATED PROTEIN EXTRACTION AND DETECTION

Cardiovascular Disease

MARKER FOR DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE

METHOD FOR TREATING HEPATOCELLULAR CARCINOMA

JUDGMENT SUPPORTING INFORMATION GENERATING METHOD, JUDGMENT SUPPORTING INFORMATION GENERATING SYSTEM, AND INFORMATION PROCESSING DEVICE

BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS

Method for separation and/or detection and/or in vitro quantification of infectious compounds in biological material

EGG ALLERGY ANTIGEN

Method for maximizing coronavirus killing activity of high-density lipoproteins, and pharmaceutical composition for preventing or treating COVID-19

RAPID ASSAY FOR APOL1 G0 PROTEIN

METHOD FOR DIAGNOSING NONALCOHOLIC STEATOHEPATITIS

METHOD FOR MEASURING STEROL IN LIPOPROTEIN

METHODS AND COMPOSITIONS FOR DIFFERENTIATING PROGRESSIVE CHRONIC KIDNEY DISEASE FROM STABLE CHRONIC KIDNEY DISEASE

COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICITY AND SENSITIVITY

Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

A NOVEL COMPLEX FORMED BETWEEN THE FLAVIVIRAL NON-STRUCTURAL NS1 PROTEIN AND PLASMA LIPOPROTEINS

KAWASAKI DISEASE DETERMINATION KIT AND KAWASAKI DISEASE DETERMINATION METHOD

Prophylactic and/or therapeutic agent of infectious diseases or inflammatory diseases

METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE

MARKERS AND THEIR USE IN BRAIN INJURY

METHOD AND KIT FOR THE DETECTION OF BILIARY TRACT CANCER

METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

Method and kit for the detection of pancreatic dysfunction

ANTIBODIES SPECIFIC FOR GLYCOSYLATED APOJ AND USES THEREOF

Device and methods

EGG ALLERGY ANTIGEN

Atypical hemolytic uremic syndrome (AHUS) biomarker proteins

DEVICE AND METHODS

METHOD FOR DIAGNOSING DEMENTIA OR DETERMINING THE RISK OF DEVELOPING DEMENTIA

ApoA1 exchange rate assays in serum

METHODS AND DEVICES FOR DETECTING DIABETIC NEPHROPATHY AND ASSOCIATED DISORDERS

METHOD FOR THE DETECTION OF APOLIPOPROTEIN E4

Peptide for treating rheumatoid arthritis and use thereof

Method and System for Identifying Human Individuals Infected with COVID-19 as Being at High Risk of Progression to Severe or Critical Disease

METHOD OF PROGNOSIS AND FOLLOW UP OF PRIMARY LIVER CANCER

HDL-ASSOCIATED PROTEIN BIOMARKER PANEL DETECTION

Method for diagnosing risk for inflammatory disease through glycan profiling

Means and methods for determining risk of type-1 diabetes by serum protein biomarkers

A METHOD FOR DIAGNOSING METABOLIC DISORDER

Biomarkers for Typing Allograft Recipients

APOE MODIFICATIONS AND USES THEREOF

BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS

ApoCIII and the Treatment and Diagnosis of Diabetes

Markers for the diagnosis of biochemical recurrence in prostate cancer

Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment

HDL-associated protein extraction and detection

MARKERS AND THEIR USE IN BRAIN INJURY

METHOD FOR OBTAINING INFORMATION ON SUBJECT'S DIABETES

Methods of using GM6 in diagnosing and treating Alzheimers disease

Method of diluting a metred quantity of a test fluid for analysis

PROPHYLACTIC AND/OR THERAPEUTIC AGENT OF INFECTIOUS DISEASES OR INFLAMMATORY DISEASES

Preventive or therapeutic agent for kidney disease

Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

Methods and kits for determining predisposition to develop kidney diseases

Uses of curcumin derivative

BIOMARKERS FOR GASTRIC CANCER AND USES THEREOF

Qualitative predictive method for differential diagnosis of pneumococcal, meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis

Methods and kits for the diagnosis and risk stratification of patients with ischemia

Method for Identifying an Agent for Treating Abnormal Kidney Function

ASSAYS FOR MEASURING BINDING KINETICS AND BINDING CAPACITY OF ACCEPTORS FOR LIPOPHILIC OR AMPHIPHILIC MOLECULES

METHODS OF PROGNOSING, DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS

Method for detecting test substance

MARKERS FOR CORONARY ARTERY DISEASE AND USES THEREOF

ApoCIII and the Treatment and Diagnosis of Diabetes

METHODS FOR DIAGNOSING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

METHODS FOR APOLIPOPROTEIN DETECTION

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

METHOD FOR PREDICTING RISK OF COGNITIVE DETERIORATION

MARKERS AND THEIR USE IN BRAIN INJURY

BIOMARKER FOR DIAGNOSIS OF NEUROMYELITIS OPTICA OR MULTIPLE SCLEROSIS AND USE THEREOF

Methods for the treatment of neurological disorders

BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN FEMALE SUBJECTS

Specific Detection of Clusterin Isoforms

Methods of diagnosing and treating cancer comprising ME1

METHOD FOR MEASURING URINARY APOE CONCENTRATION

COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT

CARDIOVASCULAR DISEASE RISK ASSESSMENT

HDL-associated protein extraction and detection

Method and kit for the detection of pancreatic dysfunction

HDL-associated protein biomarker panel detection

Method and kit for the detection of biliary tract cancer

ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

Method of assaying Apolipoprotein AI for the in vitro diagnosis of colorectal cancer

QUANTIFYING PROTEIN ISOFORMS

Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody

PIP2 AS A MARKER FOR HDL FUNCTION AND CARDIOVASCULAR DISEASE RISK

Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment

Methods and compositions related to lipoproteins in blood samples

Method for identifying an agent for treating abnormal kidney function

METHODS FOR SEPARATION AND IMMUNO-DETECTION OF BIOMOLECULES, AND APPARATUS RELATED THERETO

ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) BIOMARKER PROTEINS

METHOD FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT

SYSTEMS AND METHODS FOR POINT-OF-CARE HDL AND LDL PARTICLE ASSAY

Preventive or therapeutic agent for kidney disease

Means and methods for determining risk of type-1 diabetes by serum protein biomarkers

Mass spectrometric quantitation

ApoIII and the treatment and diagnosis of diabetes

DETECTION, MONITORING AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION

SYSTEMS AND METHODS FOR POINT-OF-CARE DETERMINATION OF HDL-C AND HDL-P

BIOMARKERS FOR OVARIAN CANCER

Protein biomarkers for immune assessment and prediction of transplant rejection

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

Atypical hemolytic uremic syndrome (aHUS) biomarker proteins

Biomarkers associated with schizophrenia

Qualitative predictive method for differential diagnosis of pneumococcal meningococcal and viral meningitis, method and kit for differential diagnosis of meningitis

Methods for assessing biospecimen integrity

PCSK9 QUANTIFICATION BY IMMUNODETECTION

Biomarkers for gastric cancer and uses thereof

Reduced graphene oxide-based biosensor and use thereof

CHOLESTEROL EFFLUX CAPACITY ASSESSMENT

COMPOSITIONS AND METHODS TO ASSESS THE CAPACITY OF HDL TO SUPPORT REVERSE CHOLESTEROL TRANSPORT

METHODS FOR CALIBRATED ION MOBILITY ANALYSIS AND USES THEREOF

Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules

Bladder carcinoma biomarkers

Phenyl glyoxal probes

FLUORESCENT IN-SITU DETECTION OF LIPID PARTICLE APOLIPOPROTEINS WITHIN PRIMARY ELECTROPHORETIC MATRIX

Cells expressing apolipoprotein E and uses thereof

Ultra-small apoB-containing particles and methods of use thereof

Methods and Devices for Detecting Kidney Damage

Methods and kits for determining predisposition to develop kidney diseases

Detection and removal of misfolded proteins/peptides

BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS

Dickkopf (DKK) Proteins as Biomarkers for Cognitive Decline Associated with Alzheimer's Disease

Atypical hemolytic uremic syndrome (AHUS) biomarker proteins

Test fluid collection system

Bladder cancer detection composition, kit, and associated methods

Cardiovascular disease risk assessment

METHODS AND COMPOSITIONS RELATING TO NEURODEGENERATIVE DISEASES

Lp(a) subform size identification using elisa

Marker for response to antidepressant therapy

Method of measuring lipoprotein's capacity to accept cholesterol

COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE

HDL-associated protein extraction and detection

CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF HUMAN SERUM PROTEIN BIOMARKERS

BIOMARKERS FOR EARLY DETECTION OF OVARIAN CANCER

ApoIII and the Treatment and Diagnosis of Diabetes

NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE

PREVENTION, THERAPY AND PROGNOSIS/MONITORING IN SEPSIS AND SEPTIC SHOCK

NON-HIGH DENSITY LIPOPROTEIN DERIVED CVD MARKERS

RAPID TESTS FOR INSURANCE UNDERWRITING

Device and method for determination of an analyte in blood

DIAGNOSTIC AND TREATMENT OF CHRONIC HEART FAILURE

Method of assessing a subject for abnormal kidney function

BIOMARKERS FOR CHRONIC TRAUMATIC ENCEPHALOPATHY

ACUTE KIDNEY INJURY

Mimetic peptides

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

Method for aiding diagnosis of Alzheimer's disease

APOLIPOPROTEIN CIII IN PRE- AND TYPE 2 DIABETES

Diagnostic assay for Alzheimer's disease

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE

Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)

Lp(a) SUBFORM SIZE IDENTIFICATION USING ZONAL GEL IMMUNO-FIXATION ELECTROPHORESIS

COMPOSITIONS AND METHODS FOR ASSESSING CARDIOVASCULAR DISEASE

Quantification of lipoproteins

Methods And Marker Combinations For Screening For Predisposition To Lung Cancer

BIOMARKERS FOR OVARIAN CANCER: Beta 2 MICROGLOBULIN

IDENTIFICATION OF SPECIFIC APOLIPOPROTEIN EPITOPES ON CIRCULATING ATHEROGENIC LOW-DENSITY LIPOPROTEIN

Phenyl glyoxal probes

Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin

COMBINATION OF SPLA2 ACTIVITY AND LP(A) CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT

Ultra-small ApoB-containing particles and methods of use thereof

Method for quantifying subfraction of cholesterol (−C) in high-density lipoprotein (HDL)

METHODS FOR IMPROVING INFLAMMATORY BOWEL DISEASE DIAGNOSIS

Methods for diagnosis and prognosis of renal injury and renal failure

Risk markers for cardiovascular disease

Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same

BIOMARKERS

METHOD OF DIAGNOSING MILD TRAUMATIC BRAIN INJURY

Methods of predicting and decreasing the risk of pregnancy loss

APOE IMMUNOTHERAPY

Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios

Method of assessing diabetic nephropathy using CD5 antigen-like

Methods of using biomarkers for predicting the outcome of an immunotherapy against cancer

ApoIII and the treatment and diagnosis of diabetes

Methods for treating and/or limiting development of diabetes

Biomarkers of immunotherapy efficacy

METHODS OF PREDICTING AND DECREASING THE RISK OF PREGNANCY LOSS

Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

ASSAYS FOR HDL BIOMOLECULAR INTERACTIONS

BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE

Methods and compositions for diagnosis or prognosis of cardiovascular disease

Diagnostic method for Alzheimer's disease

Method for evaluating renal status by determining beta-2-glycoprotein 1

COMBINATION OF SPLA2 ACTIVITY AND LP(A) CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT

ALZHEIMER'S DISEASE DIAGNOSTIC PANELS AND METHODS FOR THEIR USE

APOE immunotherapy

SERUM BIOMARKERS FOR CHAGAS DISEASE

METHODS FOR ASSESSING ATHEROGENESIS BY DETERMINING OXIDIZED PHOSPHOLIPID TO APOLIPOPROTEIN B RATIOS

Methods of using biomarkers for predicting the outcome of an immunotherapy against cancer

DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

Methods And Marker Combinations For Screening For Predisposition To Lung Cancer

Assays for Differentiating between Ischemic and Hemorrhagic Stroke in a Human Patient

Pathology biomarker assay

METHODS AND KITS FOR DETERMINING PREDISPOSITION TO DEVELOP KIDNEY DISEASES

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

BIOMARKERS AND ASSAYS FOR DIABETES

ApoIII and the treatment and diagnosis of diabetes

POLYMORPHISM IN THE APO(A) GENE PREDICT RESPONSIVENESS TO ACETYLSALICYLIC ACID TREATMENT

NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE

BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME

Methods and Devices for Detecting Kidney Transplant Rejection

SERUM PROTEOMIC FOR FINDING DIAGNOSTIC MARKERS AND FOR MONITORING THERAPEUTICAL INTERVENTION IN TREATMENT OF HEPATOCELLULAR CARCINOMA

MARKERS AND METHODS RELATING TO THE ASSESSMENT OF ALZHEIMER'S DISEASE

Devices for Detecting Renal Disorders

Methods and Devices for Detecting Kidney Damage

Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders

Computer Methods and Devices for Detecting Kidney Damage

Methods and devices for detecting obstructive uropathy and associated disorders

Methods and Devices for Detecting Glomerulonephritis and Associated Disorders

Methods for identifying compounds for the treatment of type 1 diabetes

Biomarkers for detection of early- and late-stage endometrial cancer

Methods of suppressing microglial activation

Detection of endometrial secretion markers for assessment of endometriosis

APOLIPOPROTEIN CIII IN PRE- AND TYPE 2 DIABETES

COMBINED COMPUTER DEVICE AND FACILITY AIR PURIFICATION

Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers

METHODS FOR THE TREATMENT OF DEMENTIA BASED ON APO E GENOTYPE

Methods for Predicting Trisomy 21 in a Fetus

Risk markers for cardiovascular disease

Mass Spectrometric Quantitation

Method for the Diagnosis of Diseases by Determining Apolipoprotein C-1

METHOD OF ASSAYING APOLIPOPROTEIN AI FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER

Apolipoprotein AII assay method for the in vitro diagnosis of colorectal cancer

Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer

Biomarkers for ovarian cancer

Biomarkers for early detection of ovarian cancer

Identities, specificities, and use of twenty two (22) differentially expressed protein biomarkers for blood based diagnosis of breast cancer

A Method And A Kit For Diagnosing Type 2 Diabetes, Metabolic Syndrome, Sub Clinical Atherosclerosis, Myocardial Infarct, Stroke Or Clinical Manifestations Of Diabetes

Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same

METHOD FOR DIAGNOSING HEPATIC DISEASES AND SCREENING METHOD OF MOLECULES FOR TREATMENT OF HEPATIC DISEASE

Methods of suppressing microglial activation and systemic inflammatory responses

SERUM BIOMARKERS OF HEPATITIS B VIRUS INFECTED LIVER AND METHODS FOR DETECTION THEREOF

METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES

Apolipoprotein fingerprinting technique and methods related thereto

Method for identifying type I diabetes mellitus in humans

Methods for identifying compounds for the treatment of type 1 diabetes

Methods for Identifying Compounds for the Treatment of Type 1 Diabetes

Methods for identifying agents for treating cardiovascular disease using inhibition of myeloperoxidase binding

Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer

Nucleic acid encoding apolipoprotein E-I3

Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatment

Method for Measuring Cholesterol in Remnant-Like Lipoprotein

Apo B measurement system and method

Apolipoprotein A-II isoform as a biomarker for prostate cancer

METHODS FOR THE TREATMENT OF DEMENTIA BASED ON APO E GENOTYPE

Methods and marker combinations for screening for predisposition to lung cancer

Method and test for blood serum component analysis

Methods of suppressing microglial activation

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers

Regulation ao ApoB by Hsp110 proteins and related compositions and methods

Methods of identifying agents that modulate mitochondrial function

Diagnostic method for stroke

Methods for assessing atherogenesis by determining oxidized phospholipid to apolipoprotein B ratios

Methods for the treatment of dementia based on apo e genotype

Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same

Prevention therapy and prognosis/monitoring in sepsis and septic shock

Therapeutic agents and methods for cardiovascular disease

Methods of suppressing microglial activation

Reagent for detecting risk factor of alzheimer's disease, detection kit therefor and method of detecting risk factor of alzheimer's disease using the same

Serum biomarkers for Chagas disease

Risk markers for cardiovascular disease

Compositions and methods for treating diseases

Method of diagnosing changes in the intestinal absorptive surface in an individual

Serum biomarkers of hepatitis B virus infected liver and methods for detection thereof

Specific markers for diabetes

Device for determining fish gender

Methods for identifying compounds for treating type 1 diabetes